v3.26.1
NET EARNINGS (LOSS) PER SHARE
 6 Months Ended
Jun. 27, 2026
NET EARNINGS (LOSS) PER SHARE  
NET EARNINGS (LOSS) PER SHARE

(8) NET EARNINGS (LOSS) PER SHARE

The table below provides a reconciliation between the net earnings (loss) attributable to Valmont Industries, Inc. and the weighted average share amounts used to compute both basic and diluted earnings (loss) per share:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Thirteen weeks ended

​

Twenty-six weeks ended

​

​

June 27,

​

June 28,

​

June 27,

​

June 28,

​

​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

Net earnings (loss) attributable to Valmont Industries, Inc.

​

​

​

​

​

​

​

​

​

​

​

​

Net earnings (loss) attributable to Valmont Industries, Inc.

​

$

119,918

​

$

(4,020)

​

$

227,951

​

$

83,241

Change in redemption value of redeemable noncontrolling interests

​

​

—

​

​

(26,243)

​

​

—

​

​

(26,243)

Net earnings (loss) attributable to Valmont Industries, Inc. including change in redemption value of redeemable noncontrolling interests

​

$

119,918

​

$

(30,263)

​

$

227,951

​

$

56,998

Weighted average shares outstanding (in thousands):

​

 

​

​

​

​

​

 

​

​

 

​

Basic

​

​

19,368

​

​

19,809

​

​

19,421

​

​

19,928

Dilutive effect of various stock awards

​

​

152

​

​

—

​

​

150

​

​

135

Diluted

​

​

19,520

​

​

19,809

​

​

19,571

​

​

20,063

Net earnings (loss) attributable to Valmont Industries, Inc. per share:

​

​

​

​

​

​

​

​

​

​

​

​

Basic

​

$

6.19

​

$

(1.53)

​

$

11.74

​

$

2.86

Dilutive effect of various stock awards

​

​

(0.05)

​

​

—

​

​

(0.09)

​

​

(0.02)

Diluted

​

$

6.14

​

$

(1.53)

​

$

11.65

​

$

2.84

​

In the second quarter of fiscal 2025, the Company reported a net loss. In periods in which the Company recognizes a net loss, the Company excludes the impact of outstanding stock awards from the diluted loss per share calculation, as its inclusion would have an anti-dilutive effect.

As of June 27, 2026 and June 28, 2025, there were no outstanding stock options and 39,543 outstanding stock options, respectively, with exercise prices in excess of the average market price of common stock during the respective periods. These options were anti-dilutive and, accordingly, were excluded from the computation of diluted earnings per share.